Invivyd Alternatives & Competitors
12 companies similar to Invivyd — Vaccines can only take us so far. Antibodies are the natural next step.
Companies similar to Invivyd
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
Verdiva Bio
Transforming lives by accelerating innovation in cardiometabolic health
London, United Kingdom
Rival Readout
Competing with Invivyd? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Oslo, Norway
ProfoundBio
An oncology biotherapeutics company
Woodinville, United State...
Hummingbird Bioscience
Hummingbird Bioscience is a biotherapeutics company working at the interface of AI and hum...
Singapore, Singapore
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
Woburn, United States
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Imcyse SA
Pioneering the development of Imotopes™ to prevent, stop and potentially cure autoimmune d...
Liege, Belgium
Intellia Therapeutics, Inc.
Developing curative genome editing treatments
Cambridge, United States
About Invivyd
Invivyd is a pioneering player in the biotechnology sector, founded in 2020 and headquartered in the United States. The company specializes in developing monoclonal antibodies that can address evolving viruses more effectively than the human immune system. Its proprietary technology platform sets it apart, capable of m...
Antibody Development, Viral Disease Treatment, Research and Development, Clinical Trials, Education on Antibodies
Healthcare Providers, Patients with Infectious Diseases, Long COVID Patients, Vaccine Injured Individuals, Pharmaceutical Partners
Monoclonal Antibody Development, Virus Evolution Resistance, Proprietary Technology Platform, Emergency Use Authorization, Innovative Antibody Candidates, Antibody-based Therapies, SARS-CoV-2 Treatment, Immunocompromised Protection, Viral Threat Mitigation, Biopharmaceuticals, Integrated Drug Assessment, Antibody Potency Enhancement
B2B, B2D
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Invivyd: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Invivyd on 9 Jun 2026. The 12 companies listed here were last checked between 23 Feb 2026 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
